Products  »  Ophthalmology  »  Avedro Inc.  »

Avedro Inc.

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Today, more than 100,000 eyes around the world have been treated with Avedro’s KXL® System for Accelerated Cross-Linking.

Over the past two years, Avedro’s Lasik Xtra® procedure and KXL System have positively impacted hundreds of practices worldwide. With the upcoming introduction of the KXL II™ System and the Photorefractive Intrastromal Cross-Linking (PiXL™) procedure, Avedro will offer ophthalmologists an entirely new, non-invasive way for performing refractive correction.

KXL II System

The Future of Cross-Linking

The KXL II™ System allows patterned, precise, topography-guided Accelerated Cross-Linking in just minutes by increasing the UVA power and reducing the exposure time while maintaining the same total energy on the eye as standard cross-linking.

View [External Link]

Riboflavin Family

Avedro’s scientifically-developed family of riboflavin products–VibeX Xtra™, VibeX Rapid™, ParaCel™, MedioCROSS TE and MedioCROSS M–ensure rapid diffusion and individual, sterile applications for all of your cross-linking needs.

View [External Link]